content - MSCI Immuno-oncology Index
What is the MSCI ACWI Investable Market Immuno-oncology Index?
The MSCI ACWI IMI Immuno-oncology Index aims to represent the performance of a set of companies that are associated with research, development, and commercialization of products for cancer immunotherapy, also known as Immuno-oncology. Immuno-oncology is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control and eliminate cancer.
Video - MSCI ACWI IMI Immuno-oncology Index
MSCI ACWI IMI Immuno-oncology Index
It can be utilized by institutional investors for investment universe identification, internal research, and benchmarking; by product creators as the basis of ETF’s and structured products; and asset managers looking to identify potential investment opportunities.